New stroke drug tested for safety in small trial
NCT ID NCT00821821
Summary
This study tested the safety and how the body processes an experimental drug called MCI-186 in people who had just experienced a stroke caused by a blood clot. It involved 36 participants who received the drug or a placebo within 24 hours of their stroke symptoms starting. The main goal was to see if the drug was safe and to measure its levels in the blood, not to prove it was an effective treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE AIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Erasmus Medical Center
Rotterdam, Netherlands
-
Helsinki University Central Hospital
Helsinki, Finland
-
Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle, United Kingdom
Conditions
Explore the condition pages connected to this study.